Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Regulus Therapeutics Inc

+ Add to Watchlist

RGLS:US

17.4900 USD 0.8000 4.37%

As of 20:10:00 ET on 04/24/2015.

Company Profile for Regulus Therapeutics Inc (RGLS)

Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulas's research consists of scientists from across the world.

Contact Information

Regulus Therapeutics Inc

1896 Rutherford Road
Carlsbad, CA 92008-7208
United States
Phone: 1-800-734-8587

Key Executives for Regulus Therapeutics Inc (RGLS)

Kleanthis G XanthopoulosPresident/CEODavid SzekeresCFO/Chief Acctg Officer/Gen Cnsl
Paul C GrintChief Medical OfficerNeil W GibsonChief Scientific Officer
Mary Yaroshevsky GlanvilleSenior VP:Human CapitalDaniel R ChevallardVP:Finance & Accounting
Victor KnopovVP:Pharmaceutical DevelopmentAmy ConradDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil